Literature DB >> 11090861

Ca(2+)-permeable AMPA receptors and selective vulnerability of motor neurons.

L Van Den Bosch1, W Vandenberghe, H Klaassen, E Van Houtte, W Robberecht.   

Abstract

To evaluate the role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis (ALS), we compared the sensitivity of motor neurons and that of dorsal horn neurons to kainic acid (KA). Short exposure to KA resulted in the death of motor neurons, while dorsal horn neurons were unaffected. This selective motor neuron death was completely dependent on extracellular Ca(2+) and insensitive to inhibitors of voltage-operated Ca(2+) or Na(+) channels. It was also completely inhibited by the specific AMPA antagonist LY300164 and by Joro spider toxin (JSTx), a selective blocker of AMPA receptors that lack the edited GluR2 subunit. KA selectively killed those motor neurons that stained positive for the Co(2+) histochemical staining, a measure for the presence of Ca(2+)-permeable AMPA receptors. These results suggest that Ca(2+) entry via Ca(2+)-permeable AMPA receptors is responsible for the selective motor neuron death. As the Ca(2+) permeability of the AMPA receptor is regulated by its GluR2 subunit, we stained motor neurons for GluR2. Immunoreactivity was present in all motor neurons, albeit to a variable degree. However, double-staining experiments demonstrated that motor neurons clearly expressing GluR2, also expressed Ca(2+)-permeable AMPA receptors. This indicates that despite the abundant expression of GluR2, this subunit is excluded from a subset of AMPA receptors and that the activation of these receptors is responsible for the selective motor neuron death.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11090861     DOI: 10.1016/s0022-510x(00)00414-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  58 in total

1.  AMPA receptor current density, not desensitization, predicts selective motoneuron vulnerability.

Authors:  W Vandenberghe; E C Ihle; D K Patneau; W Robberecht; J R Brorson
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

2.  Identification of translational activators of glial glutamate transporter EAAT2 through cell-based high-throughput screening: an approach to prevent excitotoxicity.

Authors:  Craig K Colton; Qiongman Kong; Liching Lai; Michael X Zhu; Kathleen I Seyb; Gregory D Cuny; Jun Xian; Marcie A Glicksman; Chien-Liang Glenn Lin
Journal:  J Biomol Screen       Date:  2010-05-27

3.  Differential localization of the GluR1 and GluR2 subunits of the AMPA-type glutamate receptor among striatal neuron types in rats.

Authors:  Y P Deng; J P Xie; H B Wang; W L Lei; Q Chen; A Reiner
Journal:  J Chem Neuroanat       Date:  2007-03-04       Impact factor: 3.052

4.  Marked synergism between mutant SOD1 and glutamate transport inhibition in the induction of motor neuronal degeneration in spinal cord slice cultures.

Authors:  Hong Z Yin; John H Weiss
Journal:  Brain Res       Date:  2012-02-09       Impact factor: 3.252

5.  Membralin deficiency dysregulates astrocytic glutamate homeostasis leading to ALS-like impairment.

Authors:  Lu-Lin Jiang; Bing Zhu; Yingjun Zhao; Xiaoguang Li; Tongfei Liu; Juan Pina-Crespo; Lisa Zhou; Wenxi Xu; Maria J Rodriguez; Haiyang Yu; Don W Cleveland; John Ravits; Sandrine Da Cruz; Tao Long; Dongxian Zhang; Timothy Y Huang; Huaxi Xu
Journal:  J Clin Invest       Date:  2019-05-21       Impact factor: 14.808

6.  Intrathecal infusion of a Ca(2+)-permeable AMPA channel blocker slows loss of both motor neurons and of the astrocyte glutamate transporter, GLT-1 in a mutant SOD1 rat model of ALS.

Authors:  Hong Z Yin; Darryl T Tang; John H Weiss
Journal:  Exp Neurol       Date:  2007-07-24       Impact factor: 5.330

Review 7.  Amyotrophic lateral sclerosis: progress and prospects for treatment.

Authors:  Michel Dib
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  Potential therapeutic drugs and methods for the treatment of amyotrophic lateral sclerosis.

Authors:  G Yacila; Y Sari
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

9.  Experimental models for the study of neurodegeneration in amyotrophic lateral sclerosis.

Authors:  Luis B Tovar-Y-Romo; Luz Diana Santa-Cruz; Ricardo Tapia
Journal:  Mol Neurodegener       Date:  2009-07-20       Impact factor: 14.195

10.  Oral administration of memantine prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis.

Authors:  In-Soo Joo; Dong-Hoon Hwang; Jung-Im Seok; Sang-Kun Shin; Seung-Up Kim
Journal:  J Clin Neurol       Date:  2007-12-20       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.